Comments

Anebulo Pharmaceuticals

ANEBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Wed Nov 13th, after the market close

Anebulo Pharmaceuticals (ANEB) Forecast

News Earnings Anebulo Pharmaceuticals (ANEB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Quotes, Forecast and News Summary

Anebulo Pharmaceuticals Stock (NASDAQ: ANEB) stock price, news, charts, stock research, profile.

Open	$1.65
Close	-
Volume / Avg.	1.28K / 8.61K
Day Range	$1.55 - $1.73
52 Wk Range	1.46 - 3.30
Market Cap	$44.86M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	0.27%
Days to Cover	3.02

Recent News

Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug

Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The company's primary focus is on developing therapy for acute cannabinoid intoxication (ACI).Total operating expenses in the second quarter of fiscal 2024 were $2.8 million compared with $3.8 million in the same period in fiscal 2023.Net loss in the second quarter of fiscal 2024 was $2.7 million, or $(0.11) per share, compared with a net loss of $3.8 million, or $(0.15) per share, in the second quarter of fiscal 2023.

Jelena Martinovic

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Lisa Levin

Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says

H.C.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.65
Close	-
Volume / Avg.	1.28K / 8.61K
Day Range	$1.55 - $1.73
52 Wk Range	1.46 - 3.30
Market Cap	$44.86M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	0.27%
Days to Cover	3.02

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

Comments

Anebulo Pharmaceuticals

Anebulo Pharmaceuticals (ANEB) Forecast

Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga